SCHEMBL22738697

SCHEMBL22738697

N=C(N)NCCC[C@@H]1NC(=O)[C@H](CCCCNC(=O)[C@H](CCCCNC(=O)CCCc2ccc(I)cc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.51
NFE2L2 Q16236 1/20 0.51
ITGB3 P05106 8/20 0.47
ITGAV P06756 8/20 0.47
ITGA5 P08648 4/20 0.47
ITGB1 P05556 2/20 0.47
ALB P02768 2/20 0.47
ITGB5 P18084 3/20 0.46
TPSAB1 Q15661 5/20 0.44
FURIN P09958 1/20 0.42
SSTR1 P30872 1/20 0.42
SSTR2 P30874 1/20 0.42
SSTR4 P31391 1/20 0.42
SSTR3 P32745 1/20 0.42
SSTR5 P35346 1/20 0.42
MC4R P32245 2/20 0.41
MC5R P33032 2/20 0.41
MC3R P41968 2/20 0.41
MC1R Q01726 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23999261 0.96 KEAP1 (0.52) KEAP1NFE2L2ITGB3ITGAVITGA5
SCHEMBL8365736 0.92 ITGB3 (0.51) KEAP1NFE2L2ITGB3ITGAVITGA5
SCHEMBL7744368 0.92 ITGB3 (0.51) KEAP1NFE2L2ITGB3ITGAVITGA5
SCHEMBL22738696 0.88 ITGB3 (0.52) KEAP1NFE2L2ITGB3ITGAVITGA5
SCHEMBL23999259 0.84 ITGB3 (0.52) KEAP1NFE2L2ITGB3ITGAVITGA5
SCHEMBL15451355 0.83 ITGB3 (0.52) KEAP1NFE2L2ITGB3ITGAVITGA5
SCHEMBL16994856 0.83 ITGB3 (0.52) KEAP1NFE2L2ITGB3ITGAVITGA5
SCHEMBL19362494 0.81 ITGB3 (0.50) ITGB3ITGAVITGA5ITGB1ITGB5
SCHEMBL7738281 0.81 ITGB3 (0.52) KEAP1NFE2L2ITGB3ITGAVITGA5
SCHEMBL14585795 0.80 ITGB3 (0.52) KEAP1NFE2L2ITGB3ITGAVITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020238800-A1 TARGETED RADIOPHARMACEUTICALS FOR TUMORS, AND COMBINATION THERAPY OF TARGETED RADIOTHERAPY THEREOF AND IMMUNOTHERAPY UNDER GUIDANCE OF IMAGES 北京大学 2020-12-03 WO disclosed